- 询价
- Promab
- 美国
- PMB-B00065
- 2025年07月15日
- Human NGF
- 66
- Human
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
CHO cells
- 亚型：
Human NGF
- 形态：
Flow cytometry, animal model study
- 保存条件：
Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
- 克隆性：
Human NGF
- 标记物：
Flow cytometry, animal model study
- 适应物种：
Human
- 保质期：
CHO cells
- 抗原来源：
Human NGF
- 目录编号：
Flow cytometry, animal model study
- 级别：
77
- 库存：
10
- 供应商：
艾美捷科技
- 宿主：
66
- 应用范围：
Human NGF
- 浓度：
55
- 靶点：
CHO cells
- 抗体英文名：
Tanezumab Biosimilar, Human NGF Monoclonal Antibody
- 抗体名：
Tanezumab 生物类似药, 人 NGF 单克隆抗体
Tanezumab 生物类似药, 人 NGF 单克隆抗体，Tanezumab Biosimilar, Human NGF Monoclonal Antibody，Tanezumab Biosimilar, Human NGF Monoclonal Antibody,Tanezumab 生物类似药, 人 NGF 单克隆抗体
产品名称：-In vivo级抗体试剂
产品货号：PMB-B00065
产品规格：询价/1mg/5mg/20mg
应用类型：Flow cytometry, animal model study
What is tanezumab biosimilar research grade? Tanezumab is a humanized IgG2-kappa monoclonal antibody against nerve growth factor (NGF) as a treatment for pain via a novel mechanisms different from conventional pain-killer drugs. NGF levels increase in the body as a result of injury, inflammation or in chronic pain states. Tanezumab selectively targets, binds to, and inhibits NGF. Tanezumab acts in the periphery in a different manner than opioids and other analgesics, including nonsteroidal anti-inflammatory drugs (NSAIDs), and in studies to date, tanezumab has not demonstrated a risk of addiction, misuse or dependence. Tanezumab biosimilar uses the same protein sequences as the therapeutic antibody tanezumab.
-In vivo级抗体试剂Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
点击：-In vivo级抗体试剂更多Promab产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料
